ARTICLE | Clinical News
RegenMed preclinical data
February 20, 2006 8:00 AM UTC
In a primate model of proliferative retinopathy, an antibody against chemokine CXC motif ligand 12 (CXCL12) (SDF-1) blocked its activity and thus prevented retinal neovascularization. SDF-1 is expres...